摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,4'R)-(+)-2-(2,2-Dimethyl-1,3-dioxolan-4-yl)-1-propanol | 71565-21-4

中文名称
——
中文别名
——
英文名称
(2S,4'R)-(+)-2-(2,2-Dimethyl-1,3-dioxolan-4-yl)-1-propanol
英文别名
(2S)-2-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]propan-1-ol;(2R,3S)-threo-3-methylbutane-1,2,4-triol 1,2-acetonide
(2S,4'R)-(+)-2-(2,2-Dimethyl-1,3-dioxolan-4-yl)-1-propanol化学式
CAS
71565-21-4
化学式
C8H16O3
mdl
——
分子量
160.213
InChiKey
ZEXONBYTDOABDB-BQBZGAKWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Aplyronine A, a potent antitumor macrolide of marine origin, and the congeners aplyronines B and C: isolation, structures, and bioactivities
    作者:Makoto Ojika、Hideo Kigoshi、Yoshifumi Yoshida、Takeshi Ishigaki、Masanori Nisiwaki、Itaru Tsukada、Masayuki Arakawa、Hisao Ekimoto、Kiyoyuki Yamada
    DOI:10.1016/j.tet.2007.02.011
    日期:2007.4
    isolated from the sea hare Aplysia kurodai together with the congeners aplyronines B (3) and C (4). The absolute stereostructure of aplyronine A (2) was determined by the instrumental analysis (mainly NMR and MS) and the enantioselective synthesis of the fragments obtained from chemical degradation of aplyronine A (2). The structures of aplyronines B (3) and C (4) were also elucidated. Cytotoxicity and
    从海兔Aplysia kurodai中分离到了一种有效的抗肿瘤大环内酯-Aplyronine A(2),以及同类的aplyronines B(3)和C(4)。通过仪器分析(主要是NMR和MS)和对苯丙氨酸A(2)的化学降解获得的片段的对映选择性合成,确定了苯丙氨酸A(2)的绝对立体结构。还阐明了鸭绿素B(3)和C(4)的结构。肾上腺素A(2)的细胞毒性和抗肿瘤活性进行了评估。
  • A Switch of Facial Selectivities Using α-Heteroatom-Substituted Aldehydes in the Vinylogous Mukaiyama Aldol Reaction
    作者:Mariko Shinoyama、Shin-ichi Shirokawa、Atsuo Nakazaki、Susumu Kobayashi
    DOI:10.1021/ol9000312
    日期:2009.3.19
    The vinylogous Mukaiyama aldol reaction (VMAR) of chiral nonracemic ketene silyl N,O-acetal with various aldehydes is demonstrated. VMAR with α-heteroatom-unsubstituted aldehydes proceeded with a high degree of anti-selectivity. In sharp contrast, moderate to high syn-selectivity was observed when α-heteroatom-substituted aldehydes were used.
    证明了手性非外消旋烯酮甲硅烷基N,O-乙缩醛与各种醛的乙烯基Mukaiyama醛醇缩合反应(VMAR)。具有α-杂原子未取代的醛的VMAR以高度的抗选择性进行。形成鲜明对比的是,当使用α-杂原子取代的醛时,观察到中等至高的合成选择性。
  • Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance
    作者:Jian Zhang、Sanshan Wang、Qi Wei、Qianqian Guo、Yingjie Bai、Shaoqiang Yang、Fuhang Song、Lixin Zhang、Xiaoguang Lei
    DOI:10.1016/j.bmc.2017.07.025
    日期:2017.10
    reasons for the drug resistance is the existence of β-lactamases especially metallo-β-lactamases such as New Delhi metallo-β-lactamase (NDM-1) and Verona Integron-encoded metallo-β-lactamase (VIM-2). The fungal natural product Aspergillomarasmine A (AMA) has proven to be a promising inhibitor of NDM-1 and VIM-2 both in vitro and in vivo. Seven new analogues of AMA were synthesized by utilizing different
    革兰氏阴性细菌对β-内酰胺类抗生素的耐药性已显示是一个至关重要的全球性健康问题。产生耐药性的主要原因之一是存在β-内酰胺酶,尤其是金属β-内酰胺酶,例如新德里金属β-内酰胺酶(NDM-1)和维罗纳整合素编码的金属β-内酰胺酶(VIM-2) )。事实证明,在体外和体内,真菌天然产物曲霉芦荟A(AMA)都是一种有前途的NDM-1和VIM-2抑制剂。通过使用不同的策略合成了七个新的AMA类似物。对这些类似物进行了生物学评估以研究AMA在体外和体内的构效关系。引人注目的铅化合物4与美罗培南组合显示出协同作用,以克服革兰氏阴性细菌(如表达NDM-1的肺炎克雷伯氏菌(BAA-2146))的抗生素抗性。
  • Studies on the stereochemistry of aplyronine A: Determination of the stereochemistry of the C21C34 fragment
    作者:Makoto Ojika、Hideo Kigoshi、Takeshi Ishigaki、Masanori Nisiwaki、Itaru Tsukada、Kazuhiro Mizuta、Kiyoyuki Yamada
    DOI:10.1016/s0040-4039(00)61370-9
    日期:1993.1
    The absolute stereochemistry of the C21C34 fragment 2 of aplyronine A (1), a potent antitumor substance of marine origin, was determined by enantioselective synthesis.
    通过对映选择性合成确定了aplyronine A(1)(一种有效的海洋来源抗肿瘤物质)的C21C34片段2的绝对立体化学。
  • Synthetic Studies on Oligomycins. Synthesis of the Oligomycin B Spiroketal and Polypropionate Portions
    作者:Masaya Nakata、Takashi Ishiyama、Shinichi Akamatsu、Youichi Hirose、Hiroshi Maruoka、Rika Suzuki、Kuniaki Tatsuta
    DOI:10.1246/bcsj.68.967
    日期:1995.3
    The oligomycin B spiroketal portion, [2S,2(2R),3S,6R,8S,8(3R),9S,10R,11S]-2-[2-(t-butyldiphenylsilyloxy)propyl]-8-[3-(hydroxymethyl)pentyl]-3,9,11-trimethyl-1,7-dioxaspiro[5.5]undecane-5,10-diol (2), and polypropionate portion, ethyl (2E,4S,5R,6R,7S,8S,9R,10S,12R,13S,14R,16E)-5-(t-butyldimethylsilyloxy)7,9-(isopropylidenedioxy)-12,13-(4-methoxybenzylidenedioxy)-4,6,8,10,12,14-hexamethyl-11-oxo-18-phenylsulfonyloctadeca-2,16-dienoate (3), have been synthesized. The C19-C21 Wittig salt, [(2S,3R)-2-ethyl-3,4-(isopropylidenedioxy)butyl]triphenylphosphonium iodide (6), prepared from 2-butene-1,4-diol via Sharpless epoxidation, was coupled with the C22-C27 aldehyde, benzyl 2,4-dideoxy-3-O-(4-methoxybenzyl)-2,4-di-C-methyl-α,β-l-galacto-hexodialdopyranoside-(1,5) (7), prepared from (Z)-2-butene-1,4-diol via Sharpless epoxidation and the Brown’s crotylboration. The resulting coupling product was transformed to the C19-C27 lactone, [3S,4R,5R,6S,6(3R,4R)]-6-[3-ethyl-4,5-(isopropylidenedioxy)pentyl]-4-(4-methoxybenzyloxy)-3,5-dimethyl-3,4,5,6-tetrahydro-2H-pyran-2-one (4). The C28-C34 organostannane compound, (2R,4S,5S,7RS)-2-(t-butyldiphenylsilyloxy)-5-methyl-7-(tributylstannyl)-4-(triethylsilyloxy)-7-[(2-trimethylsilylethoxy)methoxy]heptane (5b), was prepared from (R)-methyl 3-hydroxybutyrate via the Brown’s crotylboration and the Still’s stannylation. After lithiation of 5b with butyllithium, the resulting α-alkoxy organolithium compound was coupled with 4 and the product was converted to the C19-C34 spiroketal, [2S,2(2R),3S,6R,8S,8(3R,4R),9S,10R,11S]-2-[2-(t-butyldiphenylsilyloxy)propyl]-8-[3-ethyl-4,5-(isopropylidenedioxy)pentyl]-10-(4-methoxybenzyloxy)-3,9,11-trimethyl-1,7-dioxaspiro[5.5]undecan-5-ol (37). The synthetic 2, derived from 37, was identical to the oligomycins (A, B, C mixture) degradation product in all respects, which elucidates the absolute stereochemistry of oligomycin B (1b). The C3-C9 aldehyde, (2-trimethylsilylethoxy)methyl 2,4,6-trideoxy-3-O-(4-methoxybenzyl)-2,4,6-tri-C-methyl-d-glycero-α-l-ido-heptodialdopyranoside-(1,5) (9), was prepared from (2S)-3-(t-butyldimethylsilyloxy)-2-methylpropanal via Keck’s crotylstannane addition and Brown’s crotylboration. The aldol coupling between the zinc enolate of the C10-C16 ketone, t-butyldimethylsilyl 2,3,7,8-tetradeoxy-4-O-(4-methoxybenzyl)-3,5-di-C-methyl-α-l-xylo-octopyranosid-6-ulose (10), prepared from methyl (R)-(+)-lactate via Brown’s crotylboration and a metallated methoxyallene addition, and aldehyde 9 gave the C8-C9 syn, C9-C10 syn product, which was transformed to the oligomycin B polypropionate portion 3 through elongation of the C1-C2 and C17-C18 carbon units.
    寡霉素 B 螺酮部分,[2S,2(2R),3S,6R,8S,8(3R),9S,10R,11S]-2-[2-(叔丁基二苯基硅氧基)丙基]-8-[3-(羟甲基)戊基]-3,9,11-三甲基-1,7-二氧杂螺[5.5]十一烷-5,10-二醇 (2),以及聚丙酸乙酯部分,(2E,4S,5R,6R,7S,8S,9R,10S,12R,13S,14R,16E)-5-(叔丁基二甲基硅氧基)7、9-(异亚丙基二氧基)-12,13-(4-甲氧基亚苄基二氧基)-4,6,8,10,12,14-六甲基-11-氧代-18-苯磺酰基十八碳-2,16-二烯酸酯 (3) 的合成。由 2-丁烯-1,4-二醇通过 Sharpless 环氧化反应制备的 C19-C21 Wittig 盐[(2S,3R)-2-乙基-3,4-(异丙基亚二氧基)丁基]三苯基碘化鏻(6)与 C22-C27 醛偶联、苄基 2,4-二脱氧-3-O-(4-甲氧基苄基)-2,4-二-C-甲基-α,β-半乳-己二酰吡喃糖苷-(1,5) (7),由 (Z)-2 丁烯-1,4-二醇通过 Sharpless 环氧化反应和布朗羰基硼化反应制备。得到的偶联产物转化为 C19-C27 内酯,[3S,4R,5R,6S,6(3R,4R)]-6-[3-乙基-4,5-(异亚丙基二氧基)戊基]-4-(4-甲氧基苄氧基)-3,5-二甲基-3,4,5,6-四氢-2H-吡喃-2-酮(4)。C28-C34有机锡化合物(2R,4S,5S,7RS)-2-(叔丁基二苯基硅氧基)-5-甲基-7-(三丁基锡烷基)-4-(三乙基硅氧基)-7-[(2-三甲基硅乙氧基)甲氧基]庚烷(5b)是由(R)-3-羟基丁酸甲酯通过布朗羰基硼化和斯蒂尔烷基化反应制备的。5b 与丁锂发生石化作用后,得到的 α-烷氧基有机锂化合物与 4 发生偶联反应,产物转化为 C19-C34 螺酮醛 [2S、2(2R),3S,6R,8S,8(3R,4R),9S,10R,11S]-2-[2-(t-butyldiphenylsilyloxy)propyl]-8-[3-ethyl-4,5-(isopropylidenedioxy)pentyl]-10-(4-methoxybenzyloxy)-3,9,11-trimethyl-1,7-dioxaspiro[5.5]十一烷-5-醇(37)。从 37 中合成的 2 在所有方面都与低聚霉素(A、B、C 混合物)的降解产物相同,从而阐明了低聚霉素 B(1b)的绝对立体化学结构。C3-C9 醛,(2-三甲基甲硅烷氧基)甲基 2,4,6-三脱氧-3-O-(4-甲氧基苄基)-2,4,6-三-C-甲基-d-甘油-α-l-ido-heptodialdopyranoside-(1,5) (9),是由(2S)-3-(t-丁基二甲基甲硅烷氧基)-2-甲基丙醛通过 Keck 的巴豆烷加成法和 Brown 的巴豆烷硼化法制备的。C10-C16 酮、2,3,7,8-四甲氧基-4-O-(4-甲氧基苄基)-3,5-二-C-甲基-α-叔丁氧羰基吡喃糖苷-6-酮的烯酸锌之间的醛醇偶联(10)、由(R)-(+)-乳酸甲酯通过布朗羰基硼化和金属化甲氧基烯加成法制备,并与醛 9 反应得到 C8-C9 syn、C9-C10 syn 产物,该产物通过 C1-C2 和 C17-C18 碳单元的伸长转化为寡霉素 B 聚丙酸酯部分 3。
查看更多